Evaxion A (EVAX) Shares Outstanding (Diluted Average) (2021 - 2023)
Evaxion A (EVAX) reported Shares Outstanding (Diluted Average) of $460.0 for Q2 2023, up 2.22% on a YoY basis from $450.0 in Q2 2022, and up 2.22% quarter-over-quarter from $450.0 in Q2 2022.
Evaxion A (EVAX) Shares Outstanding (Diluted Average) (2021 - 2023) Analysis & Trends
Evaxion A has reported Shares Outstanding (Diluted Average) for 3 years, with the latest figure at $460.0 in Q2 2023.
- For the quarter ending Q2 2023, Shares Outstanding (Diluted Average) rose 2.22% year-over-year to $460.0; the trailing twelve-month figure through Jun 2023 stood at $460.0 (up 2.22% YoY), and the FY2021 full-year result was $230.0, changed N/A from the prior year.
- Shares Outstanding (Diluted Average) for Q2 2023 stood at $460.0, up from $450.0 in the prior quarter.
- The five-year high for Shares Outstanding (Diluted Average) was $590.0 in Q2 2021, with the low at $230.0 in Q1 2021.
- Historically, Shares Outstanding (Diluted Average) has averaged $396.0 across 3 years, with a median of $450.0 in 2022.
- The largest YoY upside for Shares Outstanding (Diluted Average) was 8.7% in 2022 against a maximum downside of 23.73% in 2022.
- Evaxion A's Shares Outstanding (Diluted Average) stood at $590.0 in 2021, then retreated by 23.73% to $450.0 in 2022, then gained by 2.22% to $460.0 in 2023.
- The last three Shares Outstanding (Diluted Average) figures came in at $460.0 (Q2 2023), $450.0 (Q2 2022), and $250.0 (Q1 2022), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 92.44 Mn |
| 10 | Regeneron Pharmaceuticals | 63.43 Bn | 54.67 Bn | 3.31 Bn | 107.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 460.00 |
| Jun 30, 2022 | 450.00 |
| Mar 31, 2022 | 250.00 |
| Jun 30, 2021 | 590.00 |
| Mar 31, 2021 | 230.00 |